| Literature DB >> 22170106 |
Xuan-Wei Zhou1, Kai-Qi Su, Yong-Ming Zhang.
Abstract
A white-rot basidiomycete Ganoderma spp. has long been used as a medicinal mushroom in Asia, and it has an array of pharmacological properties for immunomodulatory activity. There have been many reports about the bioactive components and their pharmacological properties. In order to analyze the current status of Ganoderma products, the detailed process of cultivation of Ganoderma spp. and development of their products are restated in this review article. These include the breeding, cultivating, extracting bioactive component, and processing Ganoderma products, etc. This article will expand people's common knowledge on Ganoderma, and provide a beneficial reference for research and industrial production.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22170106 PMCID: PMC7080118 DOI: 10.1007/s00253-011-3780-7
Source DB: PubMed Journal: Appl Microbiol Biotechnol ISSN: 0175-7598 Impact factor: 4.813
Fig. 1The breeding strategy of Ganoderma species
Fig. 2Formation strategy of DNA fingerprint of Ganoderma (revised from Zhou et al. 2006)
Fig. 3The developmental process of Lingzhi fruit body